Orphanet: Centrum voor Medische Genetica
x

Rechercher une institution

*(*) Champ obligatoire

Centrum voor Medische Genetica

  • UZ Gent
  • Center for Medical Genetics Gent
  • C. Heymanslaan 10 (Entrance 34 (Medical Research Building))
  • 9000 GENT
  • BELGIQUE
  • Statut(s) : Privé à but lucratif
  • Téléphone : +32 (0)9 332 36 03
  • Autre Téléphone : -
  • Fax : +32 (0)9 332 49 70
  • Site web
  • Contact
  • Code EUGT : EUGTBE56112

Management de la qualité

Accréditation
 Accréditation

Accréditation
Organisme
Année
Annexe technnique

CQE
 CQE

CQE organisé(s) par CEQAS

Acquired array exploratory pilot and survey
2014
Acquired microarray
2016
Acute Lymphoblastic Leukaemia
2014, 2016
Blood - Postnatal
2015, 2017
CNS (Central Nervous system) Tumours
2017
Constitutional microarray (postnatal)
2015, 2017
MRA (Molecular Rapid Aneuploidy - QF-PCR/MLPA)
2016
Myeloid Leukaemia (AML; MDS; CML)
2015, 2017
Myeloma
2017
Myeloma exploratory pilot and survey
2015
NIPT exploratory pilot
2016, 2017
PGD Blastomere/Trophectoderm array/NGS for aneuploidy pilot
2016, 2017
PGD Blastomere/Trophectoderm array/NGS for translocations pilot
2016, 2017
Pilot PGD microarray blastomere/trophectoderm
2014
Pilot Products of conception (Array/MLPA/PCR)
2014
Prenatal array exploratory pilot and survey
2014
Prenatal microarray
2016
Products of conception (Array/MLPA/QF-PCR/NGS)
2017

CQE organisé(s) par CF Network

CF (Cystic fibrosis)
2014, 2016, 2018

CQE organisé(s) par EMQN

AZF (Y-Chromosome microdeletions)
2014, 2017, 2018
BRCA (Familial breast cancer) - full scheme
2016, 2018
BRCA testing in Ovarian Cancer (v Somatic)
2017
CMT (Charcot-Marie-Tooth disease)
2015, 2017
DFNB1 (Hereditary Deafness)
2015, 2017
DM (Myotonic dystrophy)
2015, 2017
DNA-SEQ (Full)
2015, 2016, 2017
FAP (Familial Adenomatous Polyposis Colon Cancer)
2015, 2018
FRAX (Fragile X syndrome) - Full scheme
2014, 2016, 2018
HD (Huntington disease)
2015, 2017
HFE (Hereditary hemochromatosis)
2014, 2017
HNPCC (Hereditary non-polyposis colon cancer)
2015, 2017
MEN2 (Multiple Endocrine Neoplasia Type 2)
2015, 2018
NEXTGEN (NextGen DNA Sequencing - pilot scheme)
2014
NextGen DNA Sequencing (vGermline)
2016
NextGen DNA Sequencing (vSomatic)
2016
Non-invasive prenatal diagnosis-Pilot EQA scheme
2015
OI (Osteogenesis imperfecta)
2014, 2015, 2017
PWAS (Prader-Willi and Angelman syndromes)
2014, 2016, 2018
SEQ (DNA sequencing) - Full scheme
2014
SHOX (Short stature homeobox gene testing)
2015, 2017
SMA (Spinal muscular atrophy)
2014, 2016, 2018
VHL (Von Hippel-Lindau syndrome)
2014, 2016, 2018

CQE organisé(s) par GenQA

Lymphoblastic Leukaemia (ALL)
2018
Molecular Rapid Aneuploidy (MRA)
2018
Myeloid (AML/MDS/CML)
2018
Myeloma
2018
Non-invasive prenatal testing for common aneuploidies pilot
2018
Preimplantation Genetic Testing by NGS and/or arrays for trophectoderm and/or blastomere testing for chromosomal rearrangements
2018
Preimplantation Genetic Testing for monogenic disorders Stage 1
2018
Preimplantation Genetic Testing for monogenic disorders Stage 2
2018
Prenatal constitutional CNV detection (previously Prenatal microarray)
2018
Severe Intellectual Disability Interpretation Case Scenario pilot
2018
Toutes les informations et documents contenus dans ce site sont fournis uniquement à titre d'information. Ils ne visent en aucun cas à remplacer un avis médical spécialisé et ne doivent pas être utilisés comme base pour le diagnostic ou le traitement.